Non-invasive Aesthetic Treatment Market Growth & Trends
The global non-invasive aesthetic treatment market size is expected to reach USD 18.5 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 13.9% over the forecast period. Non-invasive aesthetic treatment offer benefits, such as less pain, instant results, and low cost, over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging.
According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects for the market in the coming years. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.
Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the rapidly growing population in countries, such as India and China.
Request a free sample copy or view report summary: Non-invasive Aesthetic Treatment Market Report
Non-invasive Aesthetic Treatment Market Report Highlights
- Injectable procedure is projected to be the leading procedure segment over the forecast period
- Among various injectable procedures, botulinum toxin is one of the most widely used minimally invasive treatment
- North America was the dominant regional market in 2020 accounting for a share of around 37% due to the availability and adoption of advanced treatment options in this region
- Asia Pacific is projected to register the fastest CAGR over the forecast period on account of the rising target population in the region
Non-invasive Aesthetic Treatment Market Segmentation
Grand View Research has segmented the global non-invasive aesthetic treatment market on the basis of procedure and region:
Non-invasive Aesthetic Treatment Procedure Outlook (Revenue, USD Million, 2016 - 2028)
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
Non-invasive Aesthetic Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- US.
- Canada
- Europe
- UK.
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
List of Key Players of Non-invasive Aesthetic Treatment Market
- Hologic, Inc.
- Allergan, Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- Merz Pharma
- Lumenis
- Solta Medical
- Cutera, Inc.
- Revance Therapeutics, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment